Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes

Journal of Diabetes and its Complications

Volumn 21, Issue 5, 2007, Pages 288-293

  Clausen, Peter ^a   Ekbom, Pia ^a   Damm, Peter ^a   Feldt Rasmussen, Ulla ^a   Nielsen, Birthe ^a   Mathiesen, Elisabeth R ^a   Feldt Rasmussen, Bo ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Adhesion molecules; Arterial dilatory capacity; Endothelium; Preeclampsia; Type 1 diabetes

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCERYL TRINITRATE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; LEVOTHYROXINE; METOCLOPRAMIDE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BRACHIAL ARTERY; CONTROLLED STUDY; GESTATION PERIOD; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL CARE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; ULTRASOUND; VASCULAR DISEASE;

ADULT; DENMARK; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD;

EID: 34548317342     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.03.004     Document Type: Article

References (29)

1. Adams D.H., and Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343 (1994) 831-836
2. Adams M.R., Robinson J., McCredie R., Seale J.P., Sorensen K.E., Deanfield J.E., and Celermajer D.S. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilatation in adults at risk of atherosclerosis. Journal of the American College of Cardiology 32 (1998) 123-127
3. Austgulen R., Lien E., Vince G., and Redman C.W. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 71 (1997) 53-58
4. Bevilacqua M.P., Nelson R.M., Mannori G., and Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annual Review of Medicine 45 (1994) 361-378
5. Blann A.D., and McCollum C.N. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thrombosis and Haemostasis 74 (1994) 151-154
6. Chambers J.C., Fusi L., Malik I.S., Haskard D.O., DeSwiet M., and Kooner J.S. Association of maternal endothelial dysfunction with preeclampsia. Journal of the American Medical Association 285 (2001) 1607-1612
7. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., and Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
8. Clausen P., Jensen J.S., Jensen G., Borch-Johnsen K., and Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103 (2001) 1869-1874
9. Clausen T., Djurovic S., Brosstad F.R., Berg K., and Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction?. American Journal of Obstetrics and Gynecology 182 (2000) 321-325
10. Daniel Y., Kupferminc M.J., Baram A., Geva E., Fait G., and Lessing J.B. A selective increase in plasma soluble vascular cell adhesion molecule-1 levels in preeclampsia. American Journal of Reproductive Immunology 41 (1999) 407-412
11. Dunne F.P., Chowdhury T.A., Hartland A., Smith T., Brydon P.A., McConkey C., and Nicholson H.O. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 92 (1999) 451-454
12. Ekbom P., Damm P., Feldt-Rasmussen B., Feldt-Rasmussen U., Molvig J., and Mathiesen E.R. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 24 (2001) 1739-1744
13. Feldt-Rasmussen B., Dinesen B., and Deckert M. Enzyme immunoassay: An improved determination of urinary albumin excretion in diabetics with incipient nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation 45 (1985) 539-544
14. Garner P. Type I diabetes mellitus and pregnancy. Lancet 346 (1995) 157-161
15. Greene M.F., Hare J.W., Krache M., Phillippe M., Barss V.A., Saltzman D.H., Nadel A., Younger M.D., Heffner L., and Scherl J.E. Prematurity among insulin-requiring diabetic gravid women. American Journal of Obstetrics and Gynecology 161 (1989) 106-111
16. Hackman A., Abe Y., Insull W., Pownall H., Smith L., Dunn K., Gotto A.M., and Ballantyne C.M. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93 (1996) 1334-1338
17. Higgins J.R., Papayianni A., Brady H.R., Darling M.R., and Walshe J.J. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: Evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. American Journal of Obstetrics and Gynecology 179 (1998) 464-469
18. Joannides R., Haefeli W.E., Linder L., Richard V., Bakkali E.H., Thuillez C., and Luscher T.F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91 (1995) 1314-1319
19. Krauss T., Kuhn W., Lakoma C., and Augustin H.G. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. American Journal of Obstetrics and Gynecology 177 (1997) 443-449
20. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
21. Rohde L.E., Hennekens C.H., and Ridker P.M. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arteriosclerosis, Thrombosis, and Vascular Biology 19 (1999) 1595-1599
22. Rosenn B., Miodovnik M., Combs C.A., Khoury J., and Siddiqi T.A. Poor glycemic control and antepartum obstetric complications in women with insulin-dependent diabetes. International Journal of Gynaecology and Obstetrics 43 (1993) 21-28
23. Salas S.P. What causes pre-eclampsia. Bailliere's Best Practice & Research Clinical Obstetrics & Gynaecology 13 (1999) 41-57
24. Savvidou M.D., Hingorani A.D., Tsikas D., Frölich J., Vallance P., and Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
25. Sibai B.M., Caritis S., Hauth J., Lindheimer M., VanDorsten J.P., MacPherson C., Klebanoff M., Landon M., Miodovnik M., Paul R., Meis P., Dombrowski M., Thurnau G., Roberts J., and McNellis D. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. American Journal of Obstetrics and Gynecology 182 (2000) 364-369
26. Smith M.A. Preeclampsia. Primary Care 20 (1993) 655-664
27. Sorensen K.E., Celermajer D.S., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Thomas O., and Deanfield J.E. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. British Heart Journal 74 (1995) 247-253
28. VanWijk M.J., Kublickiene K., Boer K., and VanBavel E. Vascular function in preeclampsia. Cardiovascular Research 47 (2000) 38-48
29. Yoshida A., Nakao S., Kobayashi M., and Kobayashi H. Flow-mediated vasodilatation and plasma fibronectin levels in preeclampsia. Hypertension 36 (2000) 400-404